This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Fri May 24, 2013 2:11 pm

View unanswered posts | View active topics


Board index » Multiple Sclerosis » General Discussion

All times are UTC - 8 hours [ DST ]



Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 
  Print view Previous topic | Next topic 
Author Message
squiffy2
PostPosted: Tue Mar 19, 2013 3:36 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1689
Antisense Therapeutics lowers costs for multiple sclerosis treatment support study

Antisense Therapeutics (ASX: ANP) has significantly lowered the costs associated with its planned chronic toxicology study of the drug ATL1102.

The company now expects the study, which will support a potential future phase IIb study of ATL1102 in multiple sclerosis patients, to cost less than A300,000 to complete.

Importantly, Antisense is able to fund the study without it having a material effect on cash flow forecasts which cover planned activities well into 2014..... Read More - http://www.ms-uk.org/index.cfm/MSnews

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 

Board index » Multiple Sclerosis » General Discussion

All times are UTC - 8 hours [ DST ]

Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Stay healthy - lowers MS activity SUMMARY

jackD

0

528

Sat Dec 10, 2011 10:07 am

jackD View the latest post

There are no new unread posts for this topic. Study reveals unexpected mechanism of new MS treatment

squiffy2

0

850

Wed Dec 22, 2010 12:19 am

squiffy2 View the latest post

There are no new unread posts for this topic. Study finds improvement with a new treatment option for MS

squiffy2

1

477

Sat Feb 16, 2013 2:41 am

andreagwolford View the latest post

There are no new unread posts for this topic. Acorda Therapeutics has big biotech dreams

beyondms

5

1434

Fri Jun 08, 2007 8:39 pm

CureOrBust View the latest post

There are no new unread posts for this topic. Canbex Therapeutics receives £1.75 million towards MS rx

squiffy2

0

709

Thu Mar 24, 2011 3:30 am

squiffy2 View the latest post

 


Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: